Manufacturing / Pharmaceutical Preparations
Moleculin Biotech, Inc.
MBRX
$0.45
+$0.02 (+4.25%)
Price as of Oct 9, 2026 23:59 UTC
12 M
Market Cap (Micro Cap)
Nov 11
Next Earnings
Technical Signals
as of Oct 7
Bearish
0 of 7
Trend
- Above 20-day average $0.57
- Above 50-day average $0.85
- Above 200-day average $1.78 · -75.2%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) Down · 58d ago
- Momentum cross (20/50) Down · 61d ago
Volume
- Below-average volume 0.4x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Heat Map
Delta-risk grid for MBRX options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
9 buys
0 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Aug 03, 2026 | KLEMP WALTER V | Grant | 1,599,999 | $0 | -2.3% | |
| Aug 03, 2026 | KLEMP WALTER V | Buy | 533,333 | $0 | -2.3% | |
| Aug 03, 2026 | Foster Jonathan P. | Buy | 879,999 | $0 | -2.3% | |
| Aug 03, 2026 | PICKER DONALD H | Buy | 519,999 | $0 | -2.3% | |
| Aug 03, 2026 | PICKER DONALD H | Buy | 173,333 | $0 | -2.3% | |
| Aug 03, 2026 | Foster Jonathan P. | Buy | 293,333 | $0 | -2.3% | |
| Jun 22, 2026 | KLEMP WALTER V | Tax_withholding | 88 | $275 | -86.5% | |
| Jun 22, 2026 | KLEMP WALTER V | Exercise | 360 | $0 | -86.5% | |
| Jun 22, 2026 | Foster Jonathan P. | Exercise | 174 | $0 | -86.5% | |
| Jun 22, 2026 | Foster Jonathan P. | Exercise | 174 | $0 | -86.5% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Aug 10, 2026 | Q2 2026 | -$1.57 | |||
| Mar 31, 2026 | Q1 2026 | -$1.70 | -$3.54 | -108.7% | Miss |
| Dec 31, 2025 | Q4 2025 | -$6.24 | $13.04 | +309.1% | Beat |
| Sep 30, 2025 | Q3 2025 | -$4.97 | -$17.00 | -241.9% | Miss |
| Jun 30, 2025 | Q2 2025 | -$9.26 | -$12.25 | -32.2% | Miss |
| Mar 31, 2025 | Q1 2025 | -$14.15 | -$17.25 | -21.9% | Miss |
Track MBRX with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for MBRX and your entire portfolio.